Company attributes
Industry
Location
B2X
0
CEO
Founder
Legal Name
Seelos Therapeutics, Inc.0
Legal classification
Number of Employees (Ranges)
11 – 50
Email Address
anthony.marciano@seelostx.com0
info@seelostx.com0
Phone Number
+164629321000
Number of Employees
160
Full Address
300 Park Avenue New York, NY 10022, USA0
CIK Number
Place of Incorporation
Investors
DUNS Number
0317105280
IRS Number
870,449,9670
Founded Date
2016
Stock Symbol
SEEL
Exchange
NAICS Code
325,4120
CAGE Code
8L2A80
Technologies Used
Country
Other attributes
Company Operating Status
Active
Previous Name
APRICUS BIOSCIENCES, INC.0
NEXMED INC0
Public/Private
Public0
SIC Code
2,8340
Ticker Symbol
SEEL0
Seelos Therapeutics, a clinical-stage biopharmaceutical company focused on the development of therapies for central nervous system disorders and rare diseases.
Timeline
No Timeline data yet.
Funding Rounds
Products
Acquisitions
SBIR/STTR Awards
Patents
Further Resources
No Further Resources data yet.
